Flow cytometric detection of leukemic blasts in Libyan pediatric patients with acute lymphoblastic leukemia

References

• Terwilliger T, Abdul-Hay M. Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J. 2017;7(6):e577. doi: 10.1038/bcj.2017.53
   PubMed Web of Science ®Google Scholar
• Ssenyonga N, Stiller C, Nakata K, et al. Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000–14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries. Lancet Child Adolesc Health. 2022;6(6):409–7. doi: 10.1016/S2352-4642(22)00095-5
   PubMedGoogle Scholar
• Inaba H, Pui CH. Advances in the diagnosis and treatment of pediatric acute lymphoblastic leukemia. J Clin Med. 2021;10(9):1926. doi: 10.3390/jcm10091926
   PubMed Web of Science ®Google Scholar
• Abboud M, Ghanem K, Muwakit S. Acute lymphoblastic leukemia low and middle-income countries: disease characteristics and treatments. Curr Opin Oncol. 2014;26(6):650–655. doi: 10.1097/CCO.0000000000000125
   PubMed Web of Science ®Google Scholar
• Bennett J, Catovsky D, Daniel MT, et al. The morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations. Br J Haematol. 1981;47(4):553–561. doi: 10.1111/j.1365-2141.1981.tb02684.x
   PubMed Web of Science ®Google Scholar
• Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–2405. doi: 10.1182/blood-2016-03-643544
   PubMed Web of Science ®Google Scholar
• Duffield AS, Mullighan CG, Borowitz MJ. International consensus classification of acute lymphoblastic leukemia/lymphoma. Virchows Arch. 2023;482(1):11–26. doi: 10.1007/s00428-022-03448-8
   PubMed Web of Science ®Google Scholar
• Del Principe M, De Bellis E, Gurnari C, et al. Applications and efficiency of flow cytometry for leukemia diagnostics. Expert Rev Mol Diagn. 2019;19(12):1089–1097. doi: 10.1080/14737159.2019.1691918
   PubMed Web of Science ®Google Scholar
• Arber DA, Borowitz MJ, Cessna M, et al. Initial diagnostic workup of acute leukemia: guideline from the college of American Pathologists and the American society of hematology. Arch Pathol Lab Med. 2017;141(10):1342–1393. doi: 10.5858/arpa.2016-0504-CP
   PubMed Web of Science ®Google Scholar
• Solly F, Angelot-Delettre F, Ticchioni M, et al. Standardization of flow cytometric immunophenotyping for hematological malignancies: the France flow group experience. Cytometry Pt A. 2019;95(9):1008–1018. doi: 10.1002/cyto.a.23844
   PubMed Web of Science ®Google Scholar
• Lhermitte L, Bottcher S. EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes. Leukemia. 2012;26(9):1908–1975. doi: 10.1038/leu.2012.120
   PubMed Web of Science ®Google Scholar
• DiGiuseppe J, Wood BL. Applications of flow cytometricImmunophenotyping in the diagnosis and posttreatment monitoring of B and T lymphoblastic leukemia/lymphoma. Cytometry B Clin Cytom. 2019;96(4):256–265. doi: 10.1002/cyto.b.21833
   PubMed Web of Science ®Google Scholar
• Liu YF, Wang BY, Zhang WN, et al. Genomic profiling of adult and pediatric B-cell acute lymphoblastic leukemia. EBioMedicine. 2016;8:173–183. doi: 10.1016/j.ebiom.2016.04.038
   PubMed Web of Science ®Google Scholar
• Lacombe F, Durrieu F, Briais A, et al. Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia. Leukemia. 1997;11(11):1878–1886. doi: 10.1038/sj.leu.2400847
   PubMed Web of Science ®Google Scholar
• Bene MC, Castold G, Knapp W, et al. Proposals for the immunological classification of acute leukemias. European group for the immunological characterization of leukemias (EGIL). Leukemia. 1995;9:1783–1786.
   PubMed Web of Science ®Google Scholar
• Lee HG, Baek HJ, Kim HS, et al. Biphenotypic acute leukemia or acute leukemia of ambiguous lineage in childhood: clinical characteristics and outcome. Blood Res. 2019;54(1):63–73. doi: 10.5045/br.2019.54.1.63
   PubMed Web of Science ®Google Scholar
• Paredes-Aguilera R, Romero-Guzman L, Lopez-Santaigo N, et al. Flow cytometric analysis of cell-surface and intracellular antigens in the diagnosis of acute leukemia. Am J Hematol. 2001;68(2):69–74. doi: 10.1002/ajh.1155
   PubMed Web of Science ®Google Scholar
• Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114(5):937–951. doi: 10.1182/blood-2009-03-209262
   PubMed Web of Science ®Google Scholar
• Rezaei MS, Esfandiari N, Refoua S. Characterization of immunophenotypic aberrancies in adult and childhood acute lymphoblastic leukemia: lessons from regional variation. Iran J Pathol. 2020;15(1):1–7. doi: 10.30699/ijp.2019.93974.1926
   PubMedGoogle Scholar
• Dworzak MN, Fritsch G, Fröschl G, et al. Four-color flow cytometric investigation of terminal deoxynucleotidyl transferase–positive lymphoid precursors in pediatric bone marrow: CD79a expression precedes CD19 in early B-cell ontogeny. Blood. 1998;92(9):3203–3209. doi: 10.1182/blood.V92.9.3203
   PubMed Web of Science ®Google Scholar
• Basso G, Buldini B, De Zen L, et al. New methodologic approaches for immunophenotyping acute leukemias. Haematologica. 2001;86:675–692.
   PubMed Web of Science ®Google Scholar
• Addakiri S, Bencharef H, Jaddaoui S, et al. Immunophenotype of acute lymphoblastic leukemia: the experience of University Hospital Centre Casablanca - Morocco. Clin Lab. 2023;69(9):10.7754. doi: 10.7754/Clin.Lab.2023.230307
   PubMed Web of Science ®Google Scholar
• Bawazir A, Al-Zamel N, Amen A, et al. The burden of leukemia in the Kingdom of Saudi Arabia: 15 years period (1999–2013). BMC Cancer. 2019;19(1):703. doi: 10.1186/s12885-019-5897-5
   PubMedGoogle Scholar
• Ibagy A, Silva DB, Seiben J, et al. Acute lymphoblastic leukemia in infants: 20 years of experience. J Pediatr. 2013;89(1):64–69. doi: 10.1016/j.jped.2013.02.010
   Google Scholar
• Santos MMD, Santos ASD, Santos HHM, et al. Immunophenotypic characterization of acute leukemias in Bahia, Brazil. Einstein (Sao Paulo). Einstein (São Paulo). 2023;21:eAO0117. doi: 10.31744/einstein_journal/2023AO0117
   PubMed Web of Science ®Google Scholar
• Vázquez-Cornejo E, Morales-Ríos O, Hernández-Pliego G, et al. Incidence, severity, and preventability of adverse events during the induction of patients with acute lymphoblastic leukemia in a tertiary care pediatric hospital in Mexico. PLoS One. 2022;17(3):e0265450. doi: 10.1371/journal.pone.0265450
   PubMed Web of Science ®Google Scholar
• Wimalachandra M, Prabashika M, Dissanayake M, et al. Immunophenotypic characterization of acute lymphoblastic leukemia in a flowcytometry reference centre in Sri Lanka. Ceylon Med J. 2020;65(1&2):23–27. doi: 10.4038/cmj.v65i1-2.9133
   PubMed Web of Science ®Google Scholar
• Dakka N, Bellaoui H, Khattab M, et al. Immunologic profile and outcome of childhood acute lymphoblastic leukemia (ALL) in Morocco. J Pediatr Hematol Oncol. 2007;29(8):574–580. doi: 10.1097/MPH.0b013e3181256b8f
   PubMed Web of Science ®Google Scholar
• Kaspers GJ, Veerman AJ, Van Wering ER, et al. Prognostic significance of peanut agglutinin binding in childhood acute lymphoblastic leukemia. Leukemia. 1996;10:675–681.
   PubMed Web of Science ®Google Scholar
• Dores GM, Devesa SS, Curtis RE, et al. Acute leukemia incidence and patient survival among children and adults in the United States, 2001–2007. Blood. 2012;119(1):34–43. doi: 10.1182/blood-2011-04-347872
   PubMed Web of Science ®Google Scholar
• Kakaje A, Alhalabi MM, Ghareeb A, et al. Rates and trends of childhood acute lymphoblastic leukemia: an epidemiology study. Sci Rep. 2020;10(1):6756. doi: 10.1038/s41598-020-63528-0
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay A, Gangopadhyay S, Dasgupta S, et al. Surveillance and expected outcome of acute lymphoblastic leukemia in children and adolescents: an experience from Eastern India. Indian J Med Paediatr Oncol. 2013;34(4):280–282. doi: 10.4103/0971-5851.125245
   PubMedGoogle Scholar
• Jin MW, Xu SM, An Q, et al. A review of risk factors for childhood leukemia. Eur Rev Med Pharmacol Sci. 2016;20:3760–3764.
   PubMed Web of Science ®Google Scholar
• Hjalgrim LL, Rostgaard K, Schmiegelow K, et al. Age- and sex-specific incidence of childhood leukemia by immunophenotyping in the Nordic countries. J Natl Cancer Inst. 2003;95(20):1539–1544. doi: 10.1093/jnci/djg064
   PubMedGoogle Scholar
• Maruffi M, Sposto R, Oberley MJ, et al. Therapy for children and adults with mixed phenotype acute leukemia: a systematic review and meta-analysis. Leukemia. 2018;32(7):1515–1528. doi: 10.1038/s41375-018-0058-4
   PubMed Web of Science ®Google Scholar
• Matutes E, Pickl WF, Van’t Veer M, et al. Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification. Blood. 2011;117(11):3163–3171. doi: 10.1182/blood-2010-10-314682
   PubMed Web of Science ®Google Scholar
• Rubnitz JE, Onciu M, Pounds S, et al. Acute mixed lineage leukemia in children: the experience of St Jude children’s research hospital. Blood. 2009;113(21):5083–5089. doi: 10.1182/blood-2008-10-187351
   PubMed Web of Science ®Google Scholar
• Weinberg OK, Seetharam M, Ren L, et al. Mixed phenotype acute leukemia: a study of 61 cases using World Health Organization and European group for the immunological classification of leukaemias criteria. Am J Clin Pathol. 2014;142(6):803–808. doi: 10.1309/AJCPPVUPOTUVOIB5
   PubMed Web of Science ®Google Scholar
• Weinberg OK, Arber DA. Mixed-phenotype acute leukemia: historical overview and a new definition. Leukemia. 2010;24(11):1844–1851. doi: 10.1038/leu.2010.202
   PubMed Web of Science ®Google Scholar
• Yan L, Ping N, Zhu M, et al. Clinical, immunophenotypic, cytogenetic, and molecular genetic features in 117 adult patients with mixed-phenotype acute leukemia defined by WHO-2008 classification. Haematologica. 2012;97(11):1708–1712. doi: 10.3324/haematol.2012.064485
   PubMed Web of Science ®Google Scholar
• Tian H, Xu Y, Liu L, et al. Comparison of outcomes in mixed phenotype acute leukemia patients treated with chemotherapy and stem cell transplantation versus chemotherapy alone. Leuk Res. 2016;45:40–46. doi: 10.1016/j.leukres.2016.04.002
   PubMed Web of Science ®Google Scholar